LABORATORY MONITORING OF THROMBOLYTIC THERAPY

被引：2
|
作者：
BELL, WR
机构：
来源：
CLINICS IN LABORATORY MEDICINE | 1995年 / 15卷 / 01期
关键词：
D O I：
10.1016/S0272-2712(18)30349-4
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
The rationale for monitoring the infusion of thrombolytic therapy is to establish that the plasminogen-plasmin proteolytic enzyme system (fibrinolytic system) has been therapeutically activated by the thrombolytic agent. Accurately and precisely monitoring the activity of the fibrinolytic system will facilitate improved use and safety of all thrombolytic agents currently available.
引用
收藏
页码：165 / 178
页数：14
相关论文
共 50 条
  • [1] THROMBOLYTIC THERAPY - AGENTS, INDICATIONS, AND LABORATORY MONITORING
    BELL, WR
    MEDICAL CLINICS OF NORTH AMERICA, 1994, 78 (03) : 745 - 764
  • [2] MONITORING THROMBOLYTIC THERAPY - THE NEW LABORATORY CHALLENGE
    HERMELIN, LI
    EICHELBERGER, JW
    JOURNAL OF MEDICAL TECHNOLOGY, 1985, 2 (02): : 89 - 93
  • [3] THEORETIC AND PRACTICAL CONSIDERATIONS ON LABORATORY MONITORING OF THROMBOLYTIC THERAPY
    CONARD, J
    SAMAMA, MM
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1987, 13 (02): : 212 - 222
  • [4] LABORATORY MONITORING OF THROMBOLYTIC THERAPY EMPLOYING SYNTHETIC CHROMOGENIC PEPTIDES
    MESSMORE, HL
    FAREED, J
    KNIFFIN, J
    GOSNELL, L
    CHRISTIANSEN, J
    BERMES, EW
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1979, 9 (05): : 438 - 439
  • [5] MONITORING THROMBOLYTIC THERAPY
    BOVILL, EG
    BECKER, R
    TRACY, RP
    PROGRESS IN CARDIOVASCULAR DISEASES, 1992, 34 (04) : 279 - 294
  • [6] THROMBOLYTIC THERAPY FOR ACUTE CORONARY-THROMBOSIS - AN APPROACH TO LABORATORY MONITORING
    RAPPAPORT, ES
    BARNARD, J
    WELLS, GA
    WATSON, LE
    HELBERT, B
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1984, 81 (06) : 800 - 800
  • [7] LABORATORY MONITORING DURING THROMBOLYTIC THERAPY IN CLINICAL-PRACTICE AND RESEARCH
    GRUNEWALD, M
    SEIFRIED, E
    ZEITSCHRIFT FUR KARDIOLOGIE, 1993, 82 : 129 - 135
  • [8] LABORATORY CONTROL OF THROMBOLYTIC THERAPY
    HAWKEY, C
    HOWELL, M
    JOURNAL OF CLINICAL PATHOLOGY, 1964, 17 (03) : 287 - +
  • [9] PREVENTION OF INVITRO FIBRINOGENOLYSIS DURING LABORATORY MONITORING OF THROMBOLYTIC THERAPY WITH STREPTOKINASE OR APSAC
    HOFFMANN, JJML
    VIJGEN, M
    BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (02) : 279 - 284
  • [10] LABORATORY MONITORING OF SUCCESS AND FAILURE OF THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION
    HUBER, K
    HORNYKEWYCZ, S
    GRAF, S
    GABRIEL, H
    GEPPERT, A
    FIBRINOLYSIS, 1995, 9 : 53 - 57
12345